These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28471434)

  • 1. A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.
    Tsiplova K; Zur RM; Marshall CR; Stavropoulos DJ; Pereira SL; Merico D; Young EJ; Sung WWL; Scherer SW; Ungar WJ
    Genet Med; 2017 Nov; 19(11):1268-1275. PubMed ID: 28471434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel.
    Tal-Ben Ishay R; Shil A; Solomon S; Sadigurschi N; Abu-Kaf H; Meiri G; Flusser H; Michaelovski A; Dinstein I; Golan H; Davidovitch N; Menashe I
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
    Yuen T; Carter MT; Szatmari P; Ungar WJ
    Appl Health Econ Health Policy; 2018 Aug; 16(4):481-493. PubMed ID: 29651777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome Sequencing.
    Zhou J; Yang Z; Sun J; Liu L; Zhou X; Liu F; Xing Y; Cui S; Xiong S; Liu X; Yang Y; Wei X; Zou G; Wang Z; Wei X; Wang Y; Zhang Y; Yan S; Wu F; Zeng F; Wang J; Duan T; Peng Z; Sun L
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33800913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative yield of molecular diagnostic algorithms for autism spectrum disorder diagnosis in India: evidence supporting whole exome sequencing as first tier test.
    Sheth F; Shah J; Jain D; Shah S; Patel H; Patel K; Solanki DI; Iyer AS; Menghani B; Mhatre P; Mehta S; Bajaj S; Patel V; Pandya M; Dhami D; Patel D; Sheth J; Sheth H
    BMC Neurol; 2023 Aug; 23(1):292. PubMed ID: 37543562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-pass whole genome sequencing as a cost-effective alternative to chromosomal microarray analysis for low- and middle-income countries.
    Mazzonetto PC; Villela D; Krepischi ACV; Pierry PM; Bonaldi A; Almeida LGD; Paula MG; Bürger MC; de Oliveira AG; Fonseca GGG; Giugliani R; Riegel-Giugliani M; Bertola D; Yamamoto GL; Passos-Bueno MR; Campos GDS; Machado ACD; Mazzeu JF; Perrone E; Zechi-Ceide RM; Kokitsu-Nakata NM; Vieira TP; Steiner CE; Gil-da-Silva-Lopes VL; Vieira DKR; Boy R; de Pina-Neto JM; Scapulatempo-Neto C; Milanezi F; Rosenberg C
    Am J Med Genet A; 2024 Nov; 194(11):e63802. PubMed ID: 38924610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.
    Ewans LJ; Minoche AE; Schofield D; Shrestha R; Puttick C; Zhu Y; Drew A; Gayevskiy V; Elakis G; Walsh C; Adès LC; Colley A; Ellaway C; Evans CA; Freckmann ML; Goodwin L; Hackett A; Kamien B; Kirk EP; Lipke M; Mowat D; Palmer E; Rajagopalan S; Ronan A; Sachdev R; Stevenson W; Turner A; Wilson M; Worgan L; Morel-Kopp MC; Field M; Buckley MF; Cowley MJ; Dinger ME; Roscioli T
    Eur J Hum Genet; 2022 Oct; 30(10):1121-1131. PubMed ID: 35970915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a Change in the Diagnostic Algorithm of Autism Spectrum Disorders: Evidence Supporting Whole Exome Sequencing as a First-Tier Test.
    Arteche-López A; Gómez Rodríguez MJ; Sánchez Calvin MT; Quesada-Espinosa JF; Lezana Rosales JM; Palma Milla C; Gómez-Manjón I; Hidalgo Mayoral I; Pérez de la Fuente R; Díaz de Bustamante A; Darnaude MT; Gil-Fournier B; Ramiro León S; Ramos Gómez P; Sierra Tomillo O; Juárez Rufián A; Arranz Cano MI; Villares Alonso R; Morales-Pérez P; Segura-Tudela A; Camacho A; Nuñez N; Simón R; Moreno-García M; Alvarez-Mora MI
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive prenatal diagnostics: Exome versus genome sequencing.
    Miceikaite I; Fagerberg C; Brasch-Andersen C; Torring PM; Kristiansen BS; Hao Q; Sperling L; Ibsen MH; Löser K; Bendsen EA; Ousager LB; Larsen MJ
    Prenat Diagn; 2023 Aug; 43(9):1132-1141. PubMed ID: 37355983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Next Generation Sequencing-Based Protocol for Screening of Variants of Concern in Autism Spectrum Disorder.
    Huang J; Liu J; Tian R; Liu K; Zhuang P; Sherman HT; Budjan C; Fong M; Jeong MS; Kong XJ
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence.
    Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G
    Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
    JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder.
    Tammimies K; Marshall CR; Walker S; Kaur G; Thiruvahindrapuram B; Lionel AC; Yuen RK; Uddin M; Roberts W; Weksberg R; Woodbury-Smith M; Zwaigenbaum L; Anagnostou E; Wang Z; Wei J; Howe JL; Gazzellone MJ; Lau L; Sung WW; Whitten K; Vardy C; Crosbie V; Tsang B; D'Abate L; Tong WW; Luscombe S; Doyle T; Carter MT; Szatmari P; Stuckless S; Merico D; Stavropoulos DJ; Scherer SW; Fernandez BA
    JAMA; 2015 Sep; 314(9):895-903. PubMed ID: 26325558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
    Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
    BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
    Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
    Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.
    Hayeems RZ; Bhawra J; Tsiplova K; Meyn MS; Monfared N; Bowdin S; Stavropoulos DJ; Marshall CR; Basran R; Shuman C; Ito S; Cohn I; Hum C; Girdea M; Brudno M; Cohn RD; Scherer SW; Ungar WJ
    Eur J Hum Genet; 2017 Dec; 25(12):1303-1312. PubMed ID: 29158552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
    Schwarze K; Buchanan J; Taylor JC; Wordsworth S
    Genet Med; 2018 Oct; 20(10):1122-1130. PubMed ID: 29446766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
    Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
    J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
    Clark MM; Stark Z; Farnaes L; Tan TY; White SM; Dimmock D; Kingsmore SF
    NPJ Genom Med; 2018; 3():16. PubMed ID: 30002876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis of whole genome sequencing in German clinical practice.
    Plöthner M; Frank M; von der Schulenburg JG
    Eur J Health Econ; 2017 Jun; 18(5):623-633. PubMed ID: 27380512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.